{"title":"Fucoidan-functionalized liposomal nanocarriers for targeted miR-217-5p delivery and combined antitumor treatment in pancreatic ductal adenocarcinoma.","authors":"Chunlu Tan, Yaohui Fang, Ruizhe Guo, Zhenjiang Zheng, Mingrui He, Jianchen Yang, Epiphane K Silli, Qiqi Hu, Huien Zheng, Yihui Qi, Yuqing Jiang, Shubo Xing, Yanan Sun, Michelle Joycelyn Tyahyo, Qian Li, Ying Wang","doi":"10.1016/j.nano.2026.103046","DOIUrl":null,"url":null,"abstract":"<p><p>The clinical translation of microRNA (miRNA) therapy is hindered by poor tumor specificity and inefficient delivery. In this study, we constructed a targeted nanoplatform using marine sulfated polysaccharide fucoidan (FU) to encapsulate miR-217-5p in FU-modified cationic liposomes (FU-LIP-miR) for the treatment of pancreatic ductal adenocarcinoma (PDAC), alone or in combination with gemcitabine (GEM). In this system, FU serves primarily as a targeting ligand. FU was incorporated as a functional surface ligand. Previous studies have demonstrated a high-affinity interaction between FU and P-selectin, suggesting that this interaction may contribute to the enhanced tumor-associated accumulation of FU-functionalized nanocarriers. Furthermore, FU is susceptible to degradation by H<sub>2</sub>O<sub>2</sub> within the tumor microenvironment, consequently enabling controlled drug release. Initial findings confirmed that that miR-217-5p was significantly downregulated in PDAC tissues. FU-LIP-miR promoted the tumor accumulation and delivery of miR-217-5p and restored its expression, which was accompanied by reduced PDAC cell proliferation, migration, and invasion. Notably, FU can also be employed as an active targeting ligand. FU-LIP-miR combined with GEM produced an enhanced antitumor effect and increased apoptosis in PDAC cells. In a subcutaneous xenograft model using Panc02 cells in C57BL/6 mice, the combination of FU-LIP-miR and GEM produced enhanced antitumor efficacy compared with the corresponding control treatments. This study underscores the pivotal role of FU as a versatile polysaccharide in the design of targeted delivery platforms, thereby providing a novel and promising noncoding RNA-based therapeutic approach for PDAC using polysaccharide materials.</p>","PeriodicalId":19050,"journal":{"name":"Nanomedicine : nanotechnology, biology, and medicine","volume":" ","pages":"103046"},"PeriodicalIF":4.3000,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nanomedicine : nanotechnology, biology, and medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.nano.2026.103046","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
The clinical translation of microRNA (miRNA) therapy is hindered by poor tumor specificity and inefficient delivery. In this study, we constructed a targeted nanoplatform using marine sulfated polysaccharide fucoidan (FU) to encapsulate miR-217-5p in FU-modified cationic liposomes (FU-LIP-miR) for the treatment of pancreatic ductal adenocarcinoma (PDAC), alone or in combination with gemcitabine (GEM). In this system, FU serves primarily as a targeting ligand. FU was incorporated as a functional surface ligand. Previous studies have demonstrated a high-affinity interaction between FU and P-selectin, suggesting that this interaction may contribute to the enhanced tumor-associated accumulation of FU-functionalized nanocarriers. Furthermore, FU is susceptible to degradation by H2O2 within the tumor microenvironment, consequently enabling controlled drug release. Initial findings confirmed that that miR-217-5p was significantly downregulated in PDAC tissues. FU-LIP-miR promoted the tumor accumulation and delivery of miR-217-5p and restored its expression, which was accompanied by reduced PDAC cell proliferation, migration, and invasion. Notably, FU can also be employed as an active targeting ligand. FU-LIP-miR combined with GEM produced an enhanced antitumor effect and increased apoptosis in PDAC cells. In a subcutaneous xenograft model using Panc02 cells in C57BL/6 mice, the combination of FU-LIP-miR and GEM produced enhanced antitumor efficacy compared with the corresponding control treatments. This study underscores the pivotal role of FU as a versatile polysaccharide in the design of targeted delivery platforms, thereby providing a novel and promising noncoding RNA-based therapeutic approach for PDAC using polysaccharide materials.
期刊介绍:
The mission of Nanomedicine: Nanotechnology, Biology, and Medicine (Nanomedicine: NBM) is to promote the emerging interdisciplinary field of nanomedicine.
Nanomedicine: NBM is an international, peer-reviewed journal presenting novel, significant, and interdisciplinary theoretical and experimental results related to nanoscience and nanotechnology in the life and health sciences. Content includes basic, translational, and clinical research addressing diagnosis, treatment, monitoring, prediction, and prevention of diseases.